baber/WOPTO huggingface dataset:
Patent EP-0552933-B1 (EP)
Inventor: BUTTERWORTH DAVID E
IPC: A61F13/20
Filed: 1993-01-20
Granted: 1997-06-25
Abstract: A debridement sponge made from a nonwoven fabric comprising, in a preferred form, yarn-like strands of bleached cotton fibers. In the preferred form, the strands are interconnected at multiple junctures to form fewer than 31 generally rectangular apertures per cm<2>. Moreover, each aperture has an area of 1.3 mm<2>. Furthermore, the fabric has a Calculated Strand Density of 0.17 g/cc, a Clarity Index of at least 0.75, and an Absorbent Capacity of at least 7 grams of a colored, aqueous, saline solution per gram of the fabric when compressed under a pressure of 3.3 g/cm<2>. Plug Harshness and Compression Recovery of the fabric are excellent. <IMAGE>
Patent EP-0573138-B1 (EP)
Inventor: THOMPSON NIGEL
IPC: B65D41/34
Filed: 1993-03-09
Granted: 1997-06-04
Abstract: The invention provides container closure moulded from a plastics material and comprising a crown (1), an annular skirt (2) depending from the crown and provided with a screw-thread (3) on its internal surface, a tamper-evident ring (4) connected to the free end of the annular skirt by series of frangible bridges (6) extending across an axial gap or circumferential line of weakening (5) between the ring and the skirt, said ring having on its inner surface a series of integral radially inwardly projecting protrusions (7) each having a contact surface (8) generally facing the crown, wherein each bridge is formed with a weakened portion (17) in the unscrewing direction, whereby during unscrewing of the closure fronm a container neck with a security band formation, the fracture of the bridges occurs as a resultant of tension and shear forces to give a sequential separation. <IMAGE>
Patent EP-0663823-B1 (EP)
Inventor: GALARDY RICHARD E
IPC: C07C233/47
Filed: 1993-01-04
Granted: 2000-11-22
Abstract: Synthetic mammalian matrix metalloprotease inhibitors are useful in controlling angiogenesis. These compounds are thus useful in controlling the growth of tumors and in controlling neovascular glaucomas.
Patent EP-0631552-B1 (EP)
Inventor: PARKER CORVIN L
IPC: B63B7/04
Filed: 1993-02-10
Granted: 1998-04-15
Abstract: L'objet de l'invention est de produire un canot présentant deux configurations: une configuration paquet dans laquelle le canot est plié et emboîté sous forme d'un emballage compact (fig. 5) pour le transport et le stockage; et une configuration canot (fig. 1) dans laquelle le dispositif est assemblé sous forme d'un canot rigide pour être utilisé comme tel. Le canot peut se séparer en deux ou en plusieurs sections transversales (8, 9). Chaque section est divisée en une partie bâbord et une partie tribord (10, 11, 12, 13) qui se replient ensemble de façon articulée afin de réduire la largeur du paquet. Les sections repliées s'emboîtent les unes dans les autres afin de réduire la longueur du paquet. La configuration paquet possède une longeur et une largeur réduites par rapport à la configuration canot. Des dispositifs de fixation (18) sont prévus pour fixer les parties et les sections dépliées ensemble afin d'obtenir une structure solide sous une forme de canot.
Patent EP-0630199-B1 (EP)
Inventor: ROTCEIG MARC
IPC: A47B49/00
Filed: 1993-02-25
Granted: 1997-11-19
Abstract: L'invention concerne un dispositif dont le mécanisme est masqué et les étagères toutes visibles. Il est agencé sur deux plans verticaux (1 et 2), l'un devant l'autre, parallèlement au dos des étagères. Le plan (1) de derrière supportant le mécanisme, le plan (2) de devant sur lequel s'appuient les étagères fixées sur les supports rotatifs (14). Le maintien à l'horizontale desdites étagères est assuré par deux coulisses distinctes et symétriques dans lesquelles roulent des galets que portent les supports d'étagères.
Patent EP-0630249-B1 (EP)
Inventor: SUHADOLNIK ROBERT J
IPC: A61K31/74
Filed: 1993-02-18
Granted: 2002-09-18
Abstract: Viral infection is inhibited in mammals by administration of metabolically stable, non-toxic 2',5'-oligoadenylate (2-5A) derivatives that have a dual therapeutic effect. The compounds activate the intracellular latent 2-5A dependent endoribonuclease RNase L and also inhibit the action of viral DNA polymerases. Conjugates of the 2-5A derivatives for therapeutic delivery are also described.
Patent EP-0593703-B1 (EP)
Inventor: NAGAMURA TAKASHI
IPC: F25J3/04
Filed: 1993-03-26
Granted: 1997-03-05
Abstract: Un générateur produit simultanément de l'azote très pur et de l'oxygène très pur par la liquéfaction et la rectification de l'air absorbé. L'air absorbé est rectifié dans une première colonne de rectification (4) et l'azote gazeux qui est séparé au sommet de la colonne est liquéfié dans un condenseur (8) d'azote, par l'air liquide enrichi d'oxygène qui est séparé à la partie inférieure de la première colonne de rectification. Le liquide enrichi d'oxygène est envoyé vers la partie supérieure d'une deuxième colonne de rectification (5) ayant un rebouilleur (5a) au fond de la colonne, de sorte que suite à sa rectification dans la seconde colonne de rectification, l'oxygène gazeux est dirigé depuis le haut d'un réservoir à liquide vers la partie inférieure de la troisième colonne de rectification (6). Après la rectification de l'oxygène gazeux dans la troisième colonne de rectification, celui-ci, très pur et dont les impuretés ayant un point d'ébullition supérieur à celui de l'oxygène ont été extraites par rectification, est dirigé vers la partie centrale de la quatrième colonne de rectification (7) qui possède un condenseur (7e) dans sa partie supérieure et un rebouilleur (7a) dans sa partie inférieure. Après la rectification de l'oxygène gazeux très pur dans la quatrième colonne de rectification, les impuretés ayant un point d'ébullition inférieur à celui de l'oxygène sont évacuées de la partie supérieure de cette colonne sous la forme d'un gaz non condensé et l'oxygène liquide avec un degré très élevé de pureté est séparé du fond de la colonne.
Patent EP-0638148-B1 (EP)
Inventor: SCHULZE-EYSSING HEINZ
IPC: F16C27/02
Filed: 1993-04-28
Granted: 1997-04-02
Abstract: The invention relates to a wrapped bearing bush of elastic material as a bearing for a journal or a shaft for pressing into a housing bore. The invention also relates to a journal or shaft connection comprising a first and a second component, wherein the first component carries a bearing bush and the second component is connected to a journal or shaft mounted in the bearing bush.
Patent EP-0673427-B1 (EP)
Inventor: KLIS FRANCISCUS MARIA
IPC: C12N15/56
Filed: 1993-07-07
Granted: 2003-04-02
Abstract: PCT No. PCT/EP93/01763 Sec. 371 Date Feb. 27, 1995 Sec. 102(e) Date Feb. 27, 1995 PCT Filed Jul. 7, 1993 PCT Pub. No. WO94/01567 PCT Pub. Date Jan. 20, 1994A method is provided for immobilizing an enzyme, comprising immobilizing the enzyme or a functional part thereof to the cell wall of a microbial cell using recombinant DNA techniques. The enzyme is immobilized by linking it to the C-terminal part of a protein that ensures anchoring in the cell wall. Also provided is a recombinant polynucleotide comprising a structural gene encoding an enzyme protein, a part of a gene encoding the C-terminal part of a protein capable of anchoring in a eukaryotic or prokaryotic cell wall, as well as a signal sequence, in addition to a chimeric protein encoded by the recombinant polynucleotide and a vector and a microorganism containing the polynucleotide. The microorganism is suitable for carrying out enzymatic processes on an industrial scale.
Patent EP-0648101-B1 (EP)
Inventor: PALUMBO GIANFRANCO
IPC: A61F13/53
Filed: 1993-06-25
Granted: 1999-08-11
Abstract: Structure absorbante, mince, à plusieurs couches comprenant des première et deuxième couches (1, 2) en matière fibreuse et une couche intermédiaire (5) contenant des particules d'une matière absorbante (6) formant un hydrogel et des particules d'une matière organique (7), polymère thermoplastique. Dans cette structure, les première et deuxième couches fibreuses (1, 2) s'étendent latéralement au-delà de la couche intermédiaire (5) pour former des parties (8) des bords longitudinaux. Les deux couches fibreuses (1, 2) sont soudées ensemble, avec la couche intermédiaire (5) située entre ces dernières, grâce à la fusion des particules de matière (7) organique, polymère, thermoplastique et à l'aide d'une ligne continue (10) d'adhésif qui s'étend longitudinalement sur chaque partie (8) de bord longitudinal.
Patent EP-0670699-B1 (EP)
Inventor: COATOAM GARRY W
IPC: A61C8/00
Filed: 1993-09-16
Granted: 1999-03-17
Abstract: Un procédé (Fig. 7) pour fixer un implant dentaire (10, 20, 30, 40, 50) comprend la fabrication d'un implant dentaire ayant la forme générale et la dimension s'ajustant dans la cavité osseuse d'une dent extraite, avec un prolongement cylindrique (12, 22, 23, 32, 52) s'ajustant dans un trou percé dans le fond de la cavité formée par la dent extraite. Le procédé comprend l'extraction de la dent (72) du patient, la sélection d'un canon de perçage (73) ayant la forme générale de la cavité osseuse laissée par la dent extraite et comportant un alésage traversant, l'introduction d'une mèche de perçage à travers l'alésage du canon de perçage et le perçage (75) d'un trou avec une position prédéterminée dans le fond de la cavité osseuse. L'implant dentaire (10, 20, 30, 40, 50) est choisi avec une dimension prédéterminée et il est ancré dans la cavité osseuse.
Patent EP-0667067-B1 (EP)
Inventor: BROWN PAUL ANTHONY
IPC: H04B3/54
Filed: 1993-10-20
Granted: 2001-01-03
Abstract: A power transmission network (40) is disclosed which includes input means (52) for the input of telecommunication signals having carrier frequencies greater than 1MHz onto the network (40), and a means for removing similar speech and/or data signals from the network. Preferably a network conditioning element (52) is used which includes a low pass filter portion for filtering out a low frequency high amplitude mains power signal, and a coupling element for input and/or removal of telecommunication signals from the network. In this way both speech and data signals can be transmitted at carrier frequencies of greater than 1MHz along a standard electricity distribution and/or transmission network which when conditioned provides a larger available spectrum per unit length of network and greater transmission capacity than previously known. The quiescent noise level of the conditioned network is also much reduced thus permitting lower signal injection levels for a given signal-to-noise ratio and a consequential reduction in spurious radiation from the network. <IMAGE>
Patent EP-0669304-B1 (EP)
Inventor: ICHIKAWA MASARU
IPC: C07C17/23
Filed: 1993-11-09
Granted: 1998-04-29
Abstract: A process for producing difluoromethane (CF2H2, HFC-32) at high conversion and selectivity by the reaction of dichlorodifluoromethane (CF2Cl2, CFC-12) and/or monochlorodifluoromethane (CF2ClH, HCFC-22) with hydrogen in the presence of a palladium-base catalyst.
Patent EP-0643285-B1 (EP)
Inventor: GOETZ FRITZ RAINER DR ING
IPC: G01D5/244
Filed: 1994-07-22
Granted: 2000-05-10
Abstract: A system for measuring the absolute position of the moving periodic scale of an incremental encoder or synchro-generator/resolver within and/or with respect to one of its scale segments which are periodically formed and/or bounded by the scale marks on the carrier, with two scanning elements arranged to be stationary with respect to the carrier and responding to the scale marks, which scanning elements are arranged at such a distance, referred to the length or to the circumference of the segment, respectively, from one another, that they output two sinusoidal and cosinusoidal measurement signals which are analysed for position determination on the basis of the arc tangent function by using for the correction of the analysis with respect to disturbances and inaccuracies in the encoder, the values or components of a parameter vector which is continuously redetermined in accordance with predetermined optimisation criteria during the continuing measuring operation and which identifies the measuring process. <IMAGE>
Patent EP-0641794-B1 (EP)
Inventor: ADDOR ROGER WILLIAMS
IPC: C07D405/04
Filed: 1994-08-17
Granted: 2000-10-11
Abstract: There are provided thienyl- and furylpyrrole compounds of formula I   <CHEM>  wherein   R, R1 and R2   are each independently hydrogen, halogen, NO2 or CHO, and when R1 and R2 are taken together with the carbon atoms to which they are attached, they may form a ring in which R1R2 is represented by the structure: <CHEM>   L, T, V and W   are each independently hydrogen, halogen, CN or NO2; A   is O or S; X   is CN, NO2, C1-C6 haloalkyl, S(O)mCF2R3 or C(S)NR4R5; R3   is hydrogen, F, Cl, Br, CF2H, CCl2H, CClFH, CF3 or CCl3; m   is an integer of 0, 1 or 2; R4 and R5   are each independently hydrogen, C1-C4 alkyl optionally substituted with one or more halogen atoms, or  phenyl optionally substituted with one or more halogen atoms,  NO2 groups,  CN groups, C1-C4 alkyl groups optionally substituted with one or more halogen atoms, or C1-C4 alkoxy groups optionally substituted with one or more halogen atoms; Y   is hydrogen, halogen, C1-C6 haloalkyl, S(O)mCF2R3, CN or  phenyl optionally substituted with one or more halogen atoms,  NO2 groups,  CN groups, C1-C4 alkyl groups optionally substituted with one or more halogen atoms, or C1-C4 alkoxy groups optionally substituted with one or more halogen atoms; Z   is hydrogen, halogen or C1-C6 haloalkyl; B   is R6, OR6 or CN; R6   is as defined in the specification provided that when A is S, X is S(O)mCF2R3 and Z is hydrogen, then Y is hydrogen, halogen, C1-C6 haloalkyl, S(O)mCF2R3 or CN; and further provided that when the pyrrole ring is substituted with hydrogen at each of the pyrrole carbon atoms adjacent to the ring nitrogen atom, then X cannot be CN or NO2, and their use for the control of insects and acarina.   Further provided are compositions and methods comprising those compounds for the protection of plants from attack by insects and acarina.
Patent EP-0641800-B1 (EP)
Inventor: SOHDA TAKASHI
IPC: A61K31/34
Filed: 1994-09-01
Granted: 2002-01-16
Abstract: The present invention provides novel compound of the formulas (Ia) or (I): <CHEM> wherein Q is one or two amino acid residues which may be substituted; R<3> is a carboxyl group which may be esterified or an acyl group; A is an alkylene group; B is hydrogen or an alkyl group which may be substituted or an acyl group; or a salt thereof; <CHEM> wherein R<1> and R<2> may be the same or different and each is hydrogen or a hydrocarbon residue which may be substituted; R<3>, A and B have the same definitions as those shown above; m and n each is 0 or 1; provided that where both m and n are both equal to 0, R<3> is a carboxyl group which may be esterified or an acyl group having not less than 7 carbon atoms; or a salt thereof. The compound (Ia) or (I) shows cathepsin L inhibitory and bone resorption inhibitory activities and are useful as a prophylactic/therapeutic agent for osteoporosis.
Patent EP-0653581-B1 (EP)
Inventor: PAWELZIK MANFRED
IPC: F16K11/074
Filed: 1994-10-27
Granted: 1999-01-27
Abstract: The invention relates to a mixing and shut-off valve with a handle (6) that can be moved with one degree of freedom and a valve housing (2) which has inlet and outlet openings, in which a valve-seat disc (4) is held in a manner fixed in terms of relative rotation and on which a valve-regulating disc (3) which can be rotated by means of the handle is mounted in a sealing manner, the valve-seat disc having inlet and outlet apertures which are connected to the inlet and outlet openings (23, 24, 25) and which, on the other hand, can be brought into overlap with a cut-out in the valve-regulating disc. To improve this valve, the proposal is that the outlet aperture should be arranged in the central area and the inlet apertures in the peripheral area, on a circumcircle, in the valve-seat disc and that the cut-out in the valve-regulating disc should overlap the outlet aperture and should be provided with two radial extensions (311, 312) for connection to the associated inlet apertures, the first extension being dimensioned in such a way that, with the mixing valve closed, it is situated, with the necessary spacing, between the two inlet apertures and, given a leftward rotation, moves into increasing overlap with the inlet aperture for the cold medium, while the second extension is positioned in such a way that it moves increasingly into overlap with the inlet aperture for the hot medium only after the maximum opening of the aperture for the cold medium has been reached and with further leftward rotation, this movement being such that there is at the same time a corresponding decrease in the overlap of the first extension with the inlet aperture for the cold medium. <IMAGE>
Patent EP-0655601-B1 (EP)
Inventor: BELLON WOLFGANG
IPC: F41J2/02
Filed: 1994-11-08
Granted: 1996-09-25
Abstract: A heating device for a practice target, which is heated in order to produce a thermal image with the aid of a heat source which produces a gaseous heated medium, the heat source being initiated and/or interrupted by means of a control device, at least one pyrotechnic charge which produces hot gas being used as the heat source 2, and it being possible to influence the thermal capacity and/or burning duration of the pyrotechnic charge by means of its size and/or shape.   <IMAGE>
Patent EP-0613997-B1 (EP)
Inventor: MUTOH TSUTOMU
IPC: B01J35/04
Filed: 1994-02-28
Granted: 1996-05-15
Abstract: A catalyst carrier body 10 for cleaning an exhaust gas includes two elongated metal foil sheets 11 each including some areas. These areas extend substantially in parallel with the length direction, and one of them provides a corrugated portion 12 and the other of them provides a flat portion 13. The elongated metal foil sheets 11 are stacked, rolled together and brazed such that the corrugated portion 12 of one of the foil sheet is opposed and contacts the flat portion 13 of the other of the foil sheets, thus making a rolled honeycomb structure to be used under an environment exposed to a hot exhaust gas and to heat generated by catalytic reaction. <IMAGE>
Patent EP-0672094-B1 (EP)
Inventor: KANTNER STEVEN S
IPC: H01B1/20
Filed: 1993-11-03
Granted: 1997-09-24
Abstract: A hydrophilic, pressure sensitive adhesive of a poly(ethylene oxide) derived network plasticized with an essentially non-volatile, polar plasticizer present in an amount sufficient to form a cohesive, pressure sensitive adhesive. The polymeric network is prepared from an oligomeric precursor comprising difunctional poly(ethylene glycol) moieties which have been end-capped with ethylenically unsaturation. The adhesive is useful as a biomedical adhesive for transmitting or receiving electrical signals as a component of a biomedical electrode (10). The adhesive is also useful as a drug delivery device (40) to deliver pharmaceuticals or other active ingredients to or through mammalian skin. The adhesive is also useful as a component in a skin covering (30) for protecting mammalian skin or mammalian skin openings with antimicrobial agents. A method of preparation of the adhesive is also disclosed.
Patent EP-0740595-B1 (EP)
Inventor: RHODES MICHAEL KENNETH ADRIAN
IPC: B26B27/00
Filed: 1993-12-10
Granted: 2002-07-24
Abstract: PCT No. PCT/AU93/00637 Sec. 371 Date Jan. 22, 1996 Sec. 102(e) Date Jan. 22, 1996 PCT Filed Dec. 10, 1993 PCT Pub. No. WO92/13439 PCT Pub. Date Jun. 23, 1994A cutting apparatus (10) comprising a cutting assembly (11) mounted on a mounting member/actuation member (12) which is pivotally connected to an article support member (13) having a receiving portion (14). In use a user may, by tightening his or her grip about the apparatus (10) overcome the resistance provided by the leaf spring (25) and thereby urge the free ends of the mounting member (12) and the article support member (13) together such that the incising end portion (16) of the blade assembly (11) extends through the slit (30) and engages the complementary shaped recess (14) so as to form an incision in the article (50). The user may, while maintaining sufficient pressure on the mounting member/actuating member (12), draw or slide the apparatus (10) relative to the material in a general direction indicated by arrow (51), for example, such that the cutting edge (18) cuts the portion of the material (50) which it bears against.
Patent EP-0638803-B1 (EP)
Inventor: URATA TAKEYOSHI
IPC: B01L3/00
Filed: 1993-12-17
Granted: 2001-07-18
Abstract: Un récipient transportable pour prélèvement de selles comprend: un corps de récipient tubulaire (23) pouvant contenir une solution; un bouchon (25) comportant une tige de prélèvement de selles (24); une cloison de séparation (26) placée dans le corps du récipient; un filtre (27-29); et une section d'évacuation de solution filtrée (30); la partie périphérique externe du filtre est agrafée et fixée entre une partie crantée du corps du récipient et une face terminale de la section d'évacuation (30). Ce récipient offre une surface de filtration efficace élevée et, de plus, il est facile à transporter et peut être expédié et/ou renvoyé par exemple dans un article postal tel qu'une enveloppe, ce qui rend son utilisation très intéressante.
Patent EP-0683773-B1 (EP)
Inventor: BRIEADDY LAWRENCE EDWARD
IPC: A61P3/06
Filed: 1994-02-15
Granted: 1997-09-17
Abstract: PCT No. PCT/GB94/00299 Sec. 371 Date Aug. 15, 1995 Sec. 102(e) Date Aug. 15, 1995 PCT Filed Feb. 15, 1994 PCT Pub. No. WO94/18183 PCT Pub. Date Aug. 18, 1994The invention provides a compound of formula (I), wherein n is an integer of from 0 to 2; R is an optional substituent; R1 is hydrogen or C1-6alkyl; R2 is an atom or group selected from hydrogen, C1-4alkyl (including cycloalkyl and cycloalkylalkyl), C1-4alkoxy, pyrryl, thienyl, pyridyl, 1,3-benzodioxolo, phenyl and naphthyl, which groups are optionally substituted; R3 is hydrogen, OH, C1-6alkyl, C1-6alkoxy or -O C1-6acyl; R4 is a group independently selected from C1-6alkyl (including cycloalkyl and cycloalkylalkyl), C2-6alkenyl, and C2-6-alkynyl which groups are optionally substituted; R5 is a group independently selected from C2-6alkyl (including cycloalkyl and cycloalkylalkyl), C2-6alkenyl and C2-6alkynyl, which groups are optionally substituted; or R4 and R5, together with the carbon atom to which they are attached, form a C3-7spiro cycloalkyl group which is optionally substituted; R6 and R7 are independently selected from hydrogen and C1-6alkyl; and X is an aromatic or non-aromatic monocyclic or bicyclic ring system having from 5 to 10 carbon atoms (including the two carbon atoms forming part of the thiazepine ring) wherein optionally one or more of the carbon atoms is/are replaced by heteroatom(s) independently selected from nitrogen, oxygen and sulphur, or X is an aromatic or non-aromatic monocyclic or bicyclic ring system having from 5 to 10 carbon atoms (including the two carbon atoms forming part of the thiazepine ring) wherein one or more of the carbon atoms is/are replaced by heteroatom(s) independently selected from nitrogen, oxygen and sulphur; and salts, solvates and physiologically functional derivatives thereof, pharmaceutical formulations comprising such compounds, processes for their preparation and their use in reducing bile acid uptake and hence as hypolipidaemic compounds.    <IMAGE>  (I)
Patent EP-0698108-B1 (EP)
Inventor: HADDADA HEDI
IPC: A61K35/76
Filed: 1994-05-06
Granted: 2001-11-28
Abstract: The present invention resides in use of a recombinant adenovirus of animal origin containing a heterologous DNA sequence for the preparation of a pharmaceutical composition intended for the therapeutic and/or surgical treatment of the human body.